Clinical Trial Update: Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

View source ↗

Summary

This document reports the completed PROTEKT program evaluating telmisartan (Micardis/MicardisPlus) for therapy optimization in cardiovascular diseases, includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Micardis (telmisartan)
• MicardisPlus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED